- Article metrics
- Last updated: Fri, 3 Apr 2026 2:26:37 Z
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Access & Citations
-
- 62k
- Article Accesses
-
- 1297
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 247 tweeters
- 4 Facebook pages
- 3 Google+ users
- 12 news outlets
- 1 F1000
- 5 Wikipedia page
- 1174 Mendeley
- 1 Citeulike
This article is in the 99th percentile (ranked 3,637th) of the 474,368 tracked articles of a similar age in all journals and the 77th percentile (ranked 222nd) of the 978 tracked articles of a similar age in Nature
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. The donut visual summarises attention from different sources; a breakdown is shown in the legend. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Neoantigen vaccine spurs immune response in glioblastoma
Medical Health News -
2 Minute Medicine Rewind December 24, 2018
2 Minute Medicine -
Personalized Cancer Vaccines in Clinical Trials
The Scientist Magazine
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.